New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesityOctober 9, 2026
Research New federal rules could block prescription drug imports from CanadaBy Healthcare Propulsion StaffOctober 9, 20260 LIVONIA, Mich. (WXYZ) — New federal regulations set to take effect later this month could significantly impact Americans who rely…
Tech Hospitals file lawsuit to block HHS’ 340B rebate pilot, againBy Healthcare Propulsion StaffOctober 9, 20260 The hospital industry has launched a legal rematch with the federal government over the second iteration of its pilot program…
